New Funding Awards for December 2025

Sudarshan Rajagopal of Cardiology has received a sub-award (1UG3HL180990-01) through the Stanford University for a project entitled "1/2 A Phase 2 Study of Elafin (Tiprelestat) for the Treatment of Pulmonary Arterial Hypertension (PAH)." Total funding will be $82,989.

Jessica Smokoski of General Internal Medicine has received a sub-award (R01HL178638) through the Saint Luke's Hospital (Kansas City) for a project entitled "Improving Quality in Cardiac Arrest through Resuscitation Academy Training - The IQ-CART Study." Total funding will be $280,227.

Heather Whitson of Geriatrics has received a sub-award (1R61-AG092355-01) through the University of Wisconsin - Madison for a project entitled "Interdisciplinary Infrastructure for Aging Research: Establishing the Lucidity in Alzheimer's Disease (LEAD) Network." Total funding will be $22,767.

Stacey Maskarinec of Infectious Diseases has received an award from the American Heart Association for a project entitled "Cardiac Device Infection in 2D and 3D Microphysiological Model Systems." Total funding will be $249,994.

Loretta Que of Pulmonary has received a sub-award (5R01-NR019566-06) through the Henry Ford Health System for a project entitled "Asthma and Technology in Emerging African American Adults." Total funding will be $1.

Loretta Que of Pulmonary has received an award from the American Lung Association for a project entitled "American Lung Association-Airways Clinical Research Center -COPD-OMA"" (ALA-COPD-OMA) Study.." Total funding will be $1.

Stephen Greene of Cardiology has received an award from AstraZeneca Pharmaceuticals, LP for a project entitled "REFOCUS-HTN US." Total funding will be $2,022,948.

Neha Pagidipati of Cardiology has received an award from Boehringer Ingelheim International GmbH for a project entitled "BI OBESITY+ DESIGN STUDIO - MASLD, Switch, Women's Health." Total funding will be $100,685.

Sean Pokorney of Cardiology has received an award from Biotronik, Inc. for a project entitled "Independent Core Lab." Total funding will be $584,644.

Nishant Shah of Cardiology has received an award from Kardigan Inc. for a project entitled "Biomarkers in Acute Severe Hypertension (ASH): Analysis of Clinical Blood Samples from patients presenting to the ED and/or admitted with a diagnosis of Acute Severe Hypertension or recorded SBP � 180 mmHg.." Total funding will be $219,675.

Sreekanth Vemulapalli of Cardiology has received an award from American Heart Association for a project entitled "AHA AI HCM." Total funding will be $543,793.

Danielle Brander of Cell Therapy has received an award from AstraZeneca Pharmaceuticals, LP for a project entitled "The MAVRiC Study: A Phase II Study of Disease Risk Mutation-guided Finite Duration Acalabrutinib plus Venetoclax for Relapse in CLL/SLL after First-line Finite covalent BTKi plus BCL2i combination, with or without Obinutuzumab." Total funding will be $343,639.

Cristiana Costa Chase of Cell Therapy has received an award from AstraZeneca Pharmaceuticals, LP for a project entitled "A Phase 1b/2 Study of GC012F (AZD0120), a Chimeric Antigen Receptor T-cell (CAR T) Therapy Targeting CD19 and B-cell Maturation Antigen (BCMA) in Subjects With Relapsed/Refractory Multiple Myeloma." Total funding will be $377,378.

Harry Erba of Cell Therapy has received an award from Rigel Pharmaceuticals, Inc. for a project entitled "An Open-label, Phase 1b Study of R289, an IRAK1/4 Inhibitor, in Patients with Lower-risk Myelodysplastic Syndromes (LR-MDS) Who are Relapsed/Refractory/Resistant to Prior Therapies.." Total funding will be $693,845.

Harry Erba of Cell Therapy has received an award from AstraZeneca AB for a project entitled "Study of AZD3632 Monotherapy or in Combination with Anticancer Agents in Participants with Advanced Haematologic Malignancies with KMT2Ar, NPM1m, or other Genotypes Associated with HOX Overexpression.." Total funding will be $479,848.

Matthew McKinney of Cell Therapy has received an award from Miltenyi Biomedicine for a project entitled "A Prospective, Observational, Long-term Follow-up Study for Subjects who Previously Received Zamtocabtagene Autoleucel in a United States Miltenyi Biomedicine-Sponsored Clinical Study." Total funding will be $186,990.

Andrea Sitlinger of Cell Therapy has received an award from BeOne Medicines USA, Inc. for a project entitled "A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma." Total funding will be $373,902.

David Leiman of Gastroenterology has received an award from Cinclus Pharma Holding AB for a project entitled "eGERD_CX842A2301_Healing Study A randomized, phase 3, double-blind, double-dummy, active comparator-controlled multicenter study to evaluate the efficacy and safety of 2 doses of linaprazan glurate compared to lansoprazole in 4 or 8 weeks." Total funding will be $2,500.

Kathryn Starr of Geriatrics has received a sub-award (1R41-AG087819-01A1 Rev) through Zinnia Technologies, Inc. for a project entitled "Development of Zinnia All Day (ZAD), a Zinnia TV Software Product for Caregivers to Customize Daily Playlists and Create Routine based on the Needs and Interests of the Person Living With AD/ADRD." Total funding will be $166,667.

Rani Bansal of Oncology has received an award from Stemline Therapeutics, Inc for a project entitled "Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence?A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT)?." Total funding will be $897,580.

Christopher Hoimes of Oncology has received an award from Clasp Therapeutics, Inc for a project entitled "GUARDIAN-101: A Phase 1 Dose Escalation and Expansion Study of CLSP-1025 in Adult Patients with Solid Tumors that Harbor the p53 R175H Mutation." Total funding will be $782,927.

Jeffrey Shevach of Oncology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "TulmiSTAR-02: A two-part Phase I dose escalation study of tulmimetostat (DZR123) in combination with darolutamide or abiraterone followed by open-label, randomized, Phase II dose expansion study to assess the safety and efficacy of tulmimetostat in c." Total funding will be $449,108.

John Strickler of Oncology has received an award from Pheon Therapeutics LTD for a project entitled "First-in-Human, Phase 1 Study of PHN-012, an Antibody Drug Conjugate, in Patients with Advanced Solid Tumors." Total funding will be $1,535,799.

Jamie Todd of Pulmonary has received an award from Sanofi US Services, Inc. for a project entitled "Disease Progression of CLAD and Risk Factors for Adverse Outcomes." Total funding will be $694,428.

Teresa Tarrant of Rheumatology has received an award from Amgen, Inc. for a project entitled "DAZ-304: A Long-term Extension Study of Dazodalibep in Participants with SS." Total funding will be $363,388.